Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tpiv.investors@gmail.com is the ir email.
TapImmune Inc (OTCMKTS:TPIV) Tapping Into Big Things
http://www.insiderfinancial.com/tapimmune-inc-otcmktstpiv-tapping-into-big-things/114197/
Don't get caught up in MM manipulation they will go running for the hills when a real catalysts comes into the light and investors take notice.
Loading as much as I can today, its really starting to thin out.
All the selling is MM and institutional related, they are getting rid of inventory in a uncertain market.
Obviously real TPIV investors dont care about the market in general when we are looking at a promising pipeline and an insanely low valuation.
I suspect this to clear up soon and catalysts will bring in more real investors to tighten up the market.
Buying all I can today, days like today are rare opportunities for us to get a leg up.
The A-1 warrants are not a problem, the A warrants are.
Hopefully alot of them were in the selling we have seen for the last few days.
A/A-1 no difference!
Looks like you were wrong, there were $0.10 Series A warrants
Between November 30, 2015 and December 9, 2015, holders of the Series A
warrants exercised 4,832,000
As a result of those exercises: • we received approximately $483,200 in cash for the exercise of the Series A
$483,200 in cash for the exercise of the Series A.. DART?
•
we received approximately $483,200 in cash for the exercise of the Series A Warrants and $446,000 for the exercise of the Series C Warrants (which funds we intend to use for general corporate purposes and working capital) and
•
we issued 5,712,000 shares of common stock, which amounts to approximately 8.1% of all shares outstanding immediately after such issuance.
U.S. Food & Drug Administration Grants Orphan Drug Designation
http://finance.yahoo.com/news/u-food-drug-administration-grants-205100315.html
7,320,000 $0.10 shares will hit the market Nov 28th
These groups who have been dumping this whole time are who we have to worry about.
Obviously eastern capital would have to file so they are non issue.
Empery Asset Master:
18,772,265 Warrants
Brio Capital Master Fund:
25,000,000 Warrants
Iroquois Capital Management:
8,749,975 Warrants
American Capital Management:
37,500,000 Warrants
A-1 Warrant, $0.10 exercisable November 28, 2015
Each Series A-1 Warrant, as amended, will have an initial exercise price of $0.10 per share, will be exercisable beginning on November 28, 2015 and will expire on the five year anniversary of the date of issuance.
Any one worried about 12,320,000 $.10 shares showing up November 28th?
TapImmune RODMAN & RENSHAW PRESENTATION
http://www.wsw.com/webcast/rrshq25/tpiv
Dr. John N. Bonfiglio update and will review Phase ll
JACKSONVILLE, Fla., Sep. 2, 2015 /PRNewswire/ -- TapImmune, Inc. ( OTCQB: TPIV), a clinical-stage immunotherapy company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, will be featured as a presenting company at the 17th Annual Rodman & Renshaw Global Investment Conference. Sponsored by H.C. Wainwright & Co., LLC., the presentation will take place Wednesday, September 9th, 3.00-3.25 p.m. EDT in Louis XVI B (2nd floor) at the St Regis Hotel in New York City.
The presentation will be webcast live and will be archived for 90 days. Access is provided through the following link: http://wsw.com/webcast/rrshq25/tpiv.
Dr. John N. Bonfiglio, Board member and Strategic Advisor to TapImmune will present an overall update and will review TapImmune's currently planned Phase ll clinical development program in breast and ovarian cancer.
Glynn Wilson Ph.D., CEO and Chairman of TapImmune said, "We have made significant clinical progress over the past year with the completion of Phase I clinical trials in Her2/neu breast and breast and ovarian cancer. This conference is an ideal opportunity for TapImmune to provide an update on these trials and our entry into Phase II clinical programs."
SeeThru Equity September 10th Presenting Companies
http://steconference.com/presenting-companies/
I expect a move up approaching this date.
TapImmune, Inc. (OTCQB: TPIV)
TapImmune’s technology has broad applications in developing therapeutic and preventative vaccines.
Our strategy is to build a patented proprietary and unique product pipeline to capitalize on the breadth of the technology platforms we have developed or own and through collaborative partnerships and license agreements.
GMP manufacturing of peptides for Phase II trials is already underway
"For example, GMP manufacturing of peptides for Phase II trials is already underway and final analysis of clinical plans and clinical sites for the treatment of triple negative breast cancer is nearing completion for the start of Phase II studies later in 2015," Dr. Wilson added.
Cant wait for more details! Maybe next week?
http://www.prnewswire.com/news-releases/phase-i-study-in-ovarian--breast-cancer-published-in-abstracts-of-2015-asco-annual-meeting-300084044.html
T cell responses were observed in 20 of 21 patients with immune response
Very impressive!
http://www.prnewswire.com/news-releases/phase-i-study-in-ovarian--breast-cancer-published-in-abstracts-of-2015-asco-annual-meeting-300084044.html
TapImmune Receives $1,000,000 from Billionaire Kenneth Dart's Eastern Capital
http://finance.yahoo.com/news/tapimmune-receives-1-000-000-123000897.html
http://www.insidermonkey.com/blog/kenneth-dart-eastern-capital-exercise-ibio-warrants-268667/
According to the fillings he has invested allot of his own money, always good to see from management!
good news for us Sefton Still Negotiating On Financing As Oil Price Fall Impacts Process
http://www.lse.co.uk/AllNews.asp?code=7zt20cxf&headline=Sefton_Still_Negotiating_On_Financing_As_Oil_Price_Fall_Impacts_Process
Sir if you review the fillings you will see management has constantly been writing personal checks into the company, you will also see they are not being paid and many of these assets they owned before Hawker Energy and they have merged them into the company for shares.
Please do some research before you post such statements.
Could This Emerging Drug Developer Really Be Worth A Billion Dollars In Five Years?
http://www.marketwatch.com/story/could-this-emerging-drug-developer-really-be-worth-a-billion-dollars-in-five-years-2014-11-17
TapImmune Announces Phase II Clinical Trials Collaboration With VGTI Florida to Advance Breast and Ovarian Cancer Vaccines
How high is this going?
sure is
nice
Check out hawkerenergy.com
It’s called a reverse merger, clearance.co is a huge revenue producer with attractive growth, they are now public thanks to the merger.
Now they are free to raise capital and provide their investors with liquidity and flexibility.
This is done every day by company's big and small including Apple and Facebook.
You can tell this is not a pump and dump due to the majority of shares being restricted, they are looking to grow a company not dump stock, they cant dump what they cant sell.
The company has audited financials showing profits and growth, also the CEO has an amazing track record.
There are plenty of company's that started this way and have up-listed to the NASDAQ.
Meet The World’s First Publicly Traded Tech Incubator
http://techcitynews.com/2014/06/05/meet-the-worlds-first-publicly-traded-tech-incubator/
DLPM in the Wall Street Journal!
http://online.wsj.com/article/PR-CO-20140520-906869.html
DLPM is the second result on Google for eCommerce!
https://www.google.com/search?q=ecommerce&oq=ec&aqs=chrome.0.69i59l2j69i60l3j69i57.3273j0j4&sourceid=chrome&es_sm=122&ie=UTF-8#q=ecommerce
Nice! Looks like they are trapping the shorts, good buy!
Development Capital Clearance.co video
DEVELOPMENT CAPITAL Acquires Clearance.co
http://online.wsj.com/article/PR-CO-20140404-906434.html
Big news these low cost ecom sites are cash cows..
http://clearance.co/
I know a similar site raised $52 Million.
http://www.businesswire.com/news/home/20131101005524/en/nomorerack-Secures-40M-Series-Funding#.Uz7LGfldV48
http://techcrunch.com/2012/11/30/flash-deals-site-nomorerack-raises-12m-hits-5-8m-members/
Im keeping a close eye on this one.